A Missed Opportunity: Tophaceous Gout - 21/05/15
Doi : 10.1016/j.amjmed.2015.01.039
Tal Gazitt, MD, MSc a, ⁎ 
, Jenna Thomason, MD, MPH b, Grant C. Hughes, MD a, c
, Jenna Thomason, MD, MPH b, Grant C. Hughes, MD a, c a Division of Rheumatology, University of Washington School of Medicine, Seattle, Wash
b Department of Medicine, University of Washington School of Medicine, Seattle, Wash
c Department of Rheumatology, Harborview Medical Center, Seattle, Wash
∗Requests for reprints should be addressed to Tal Gazitt, MD, MSc, Division of Rheumatology, University of Washington School of Medicine, 1959 NE Pacific St., BB561 Box 356428, Seattle, WA 98195-6428.
Aimee K. Zaas, MD, Thomas J. Marrie, MD, Section Editors
Le texte complet de cet article est disponible en PDF.Plan
| Funding: No grant funding was used in the preparation of this manuscript. |
|
| Conflict of Interest: None. |
|
| Authorship: All authors had access to the medical data reviewed in this manuscript and contributed to the writing of this manuscript. |
© 2015
Elsevier Inc. Tous droits réservés.
Vol 128 - N° 6
P. 571-573 - juin 2015 Retour au numéro
Article précédent
- When and How to Recommend ‘Alternative Approaches’ in the Management of High Blood Pressure
- Robert D. Brook, Elizabeth A. Jackson, Paolo Giorgini, Cheri L. McGowan
- Back from the Brink: Catastrophic Antiphospholipid Syndrome
- Tanush Gupta, Sahil Khera, Dhaval Kolte, Wilbert S. Aronow, Tarunjit Singh, Sowmya Pinnamaneni, John T. Fallon, William H. Frishman, Alan Gass
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?